Survey on Pre-ECT Evaluation and ECT Application

Depression Clinical Trial

Official title: Multicenter Assessment of Pre-Electroconvulsive Therapy (ECT) Evaluation and ECT Application

Status Recruiting

Clinical Trial Summary

The aim of this study is to identify specifics of pre-ECT assessments and ECT application in European psychiatric services. We will engage European centres that provide ECT for psychiatric patients and for psychiatric indications. It could bring better insights on current standards and possibly give some further improvements in the field of European ECT practices.

Clinical Trial Description

Electroconvulsive therapy (ECT) is an extremely important therapeutic method in the treatment of certain psychiatric conditions. Its' effect has been demonstrated in many clinical trials, and the indications for the use of ECT are clearly defined. Thus, the absolute indications for the use of ECT are catatonia and malignant neuroleptic syndrome, while the relative indications for ECT are therapy-resistant schizophrenia, depression and chronic suicidality. When the lead psychiatrist sets an indication for the use of ECT, pre-ECT evaluation is conducted. Although the pre-evaluation aims to assess the psychophysical condition of the patient and to determine the potential risks and possible side effects of such therapy, no clear algorithm of procedures is specified. There is no data on clear guidelines for the necessary processing prior to the application of ECT, both at national levels and globally. The assessment recommendations, however, are very broad, and most of them are focused on the ethical issues of applying ECT. The standardized pre-ECT evaluation would provide physicians and patients a systematic and evidence-based risk assessment and presumption of adverse reaction profiles. ;

Related Conditions & MeSH terms

• Catatonia
• Depression
• Malignant Neuroleptic
• Neuroleptic Malignant Syndrome
• Psychotic Disorders
• Schizoaffective Disorder
• Schizophrenia
• Suicidal Intention

• NCT number: NCT04335916
• Study type: Observational
• Source: Klinicki Bolnicki Centar Zagreb
• Contact: Sara Medved
• Phone: +38512388888
• Email: smedved@kbc-zagreb.hr
• Status: Recruiting
• Start date: April 1, 2020
• Completion date: November 1, 2020